摘要

The prevalence of allergic disorders, such as asthma, has increased worldwide. Indoor allergen exposures were positively associated with persistent respiratory symptoms. Allergen vaccine is recommended as a therapeutic vaccine for allergic diseases. Asthmatics need inhaled corticosteroids to reduce symptoms, but this increases the risk of side effects. The paper under evaluation offers a steroid-sparing effect of subcutaneous standardized quality-standardized specific immunotherapy in house dust mite allergic asthmatics. This study was finished in allergic asthmatics with a double-blind, placebo-controlled study.

全文